Implant Sciences (OTCQB:IMSC) is the leader in next generation Explosives Trace Detection (ETD), and established counter-terrorism technology that detects and identifies threats from the small amounts left behind after a person handles explosives. Implant Sciences' security solutions are used worldwide for aviation, public transport, customs, air cargo, critical infrastructure, ports/ borders, and emergency response. The Company has thousands of units deployed to over 50 countries, and its trace detectors have been successfully used at the Sochi Olympics, Beijing Olympics, the Universiade Games, and the Special Olympics. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. With advanced capabilities including superior sensitivity, automatic internal calibration, rapid clear-down, ush button maintenance, and administration of trace detection. Company's handheld QS-H150 and desktop QS-B220 simplify the use, maintenance, and administration of trace detection. www.implantsciences.com

1. THE NEW STANDARD IN TRACE DETECTION
Corporate Overview
Glenn Bolduc
President & CEO

2. Safe Harbor Statement
During today’s presentation, we will make certain “forward-looking statements” as
that term is defined in the Private Securities Litigation Reform Act of 1995. Such
statements are based on management's current expectations and are subject to
risks and uncertainties that could cause the Company's actual results to differ
materially from the forward-looking statements.
Such risks and uncertainties include, but are not limited to, the risks that our
explosives detection products and technologies (including any new products we may
develop) may not be accepted by the Transportation Security Administration or by
other U.S. or foreign government and law enforcement agencies or commercial
consumers of security products; economic, political and other risks associated with
international sales and operations could adversely affect our sales; our business is
subject to intense competition and rapid technological change; the risks that our
markets are subject to technological change and that our success depends on our
ability to develop and introduce new products; and other risks and uncertainties
described in our filings with the Securities and Exchange Commission, including its
most recent Forms 10-K, 10-Q and 8-K. Such statements are based on
management's current expectations and assumptions which could differ materially
from the forward-looking statements.
Company Confidential 2

3. An American Security Innovator
Implant Sciences is proud to be contributing to the
worldwide fight against terrorism
Company Confidential 3

4. About Implant Sciences (IMSC)
Company Confidential 4
Proven provider of explosives & drugs
trace detection equipment
• Our systems detect microscopic amounts left
behind after person handles explosives or drugs
• Global customer base, large U.S. opportunity
• Over 2,000 systems sold in more than 50 countries
• Strong cadre of industry veterans
• Presence in government and corporate markets
Innovator in trace detection technology
• Unmatched technology, new product
• Strong IP portfolio: 17 patents, 6 pending

5. The Challenge
More bomb attacks, new targets
• Critical infrastructure
• Public transportation
Changing tactics
• Shoe bomber
• Underwear bomber
• Printer cartridge bomb
Different types of threats
• “Home-grown” terrorism increasing
• Smuggling and narco-terrorism
Company Confidential 5
New answers are needed to fight the evolving threat

6. Problems with Existing Methods
• Lack of privacy and dignity
• Concerns over radioactive
materials
• Clogged security checkpoints
• Operational availability
• Growing security costs
Company Confidential 6

7. Implant Sciences’ Technology
Patented technology
• inCal™ automatic internal calibration
• Non-radioactive IMS analysis
• Non-contact vortex collector
Engineered for the real world
• Low maintenance, low TCO
• Rapid clear-down
• No rest breaks required
• Identifies substances by name
Company Confidential 7
“[The industry] will develop
a non-contact (non-
swabbing) sampling
approach which eliminates
the inconsistencies that
plague manual swabbing
and allows targets of varied
surface types, structures,
and materials to be
sampled efficiently.”
-Homeland Security
Research Corporation

8. Implant Sciences’ Vision
Improving science with innovative IP
The non-contact sampling alternative
• Screening with dignity
• Integrated solutions to unclog
security checkpoints
• Layered security approach
Company Confidential 8
Homeland Security Research Corporation
states that there is “no competitive explosives
and narcotics trace detection modality on the
horizon” to compete with today’s trace
detection systems.

9. Implant Sciences’ Products
Company Confidential
Industry leading design
• No radioactive materials
• Low operating expense
• Rapid detection, fast clear-down
• inCalTM fully automatic internal calibration
QS-H150 Handheld Explosives Trace Detector
• Choice of non-contact or wipe sampling
• Flexibility for Risk-Based Screening CONOPS
QS-B220 Desktop Explosives & Drugs Trace Detector
• Small footprint ideal for crowded checkpoint
• Drug detection capability opens new markets
9

10. The New Standard in Trace Detection
Company Confidential 10

11. Global Presence in Various Applications
Company Confidential 11
Over 2,000 systems sold in
over 50 countries
Strong BRIC Presence
Africa, EU, & Mid-East growth
Focus on U.S. Penetration

12. Growing Momentum for QS-B220
Jan 2013 TSA Approval for Cargo Screening
Jul 2013 TSA Approval for Passenger and Baggage Screening
Sept 2013 STAC Approval for Cargo, Passenger, and Baggage Screening
Oct 2013 Added to TSA Qualified Products List for Cargo Screening
Oct 2013 Designated as Qualified Anti-Terrorism Technology by DHS
Feb 2014 Qualified Testing & Evaluation for TSA Checkpoint complete
Currently In final stage of TSA checkpoint qualification – OT&E (field trial)
Company Confidential 12
Looking ahead… TSA Checkpoint and Baggage Qualification
(expected June 2014)

13. 2012 2013 2014 2015 2016
Growing IMSC Market Opportunity
Company Confidential 13
Aviation Security – 46%
Customs & Borders
Government
Public Events
Seaports
Rail
Education
Commercial
Military and Police
ETD Market Segments
Source: IMS Research, and Management Estimates
Handheld
Systems
Desktop
Systems
Implant Sciences’ Market Opportunity
TSA Checkpoint
and Baggage
Qualification
Focus on regulatory
approvals grows
IMSC opportunity.
ACSTL
STAC
350% market
opportunity growth
2012-2106.
PotentialProductRevenue

14. Growth Strategy
Expand U.S. market penetration
• Dedicated government sales team in place now
• Negotiate IDIQ with TSA for checkpoint and baggage
• Leverage QPL status with other agencies
Enhance international sales, marketing & distribution
• STAC certification opens the European market
• QPL with STAC provides greatly expanded global reach
• Collaboration opportunity with other security providers
IP Leverage
• New products, new technologies
• Licensing
• Development agreements
Company Confidential 14

15. High Profile Board of Directors/Advisors
Company Confidential 15
Howard Safir (Board Member)
• Former NYC Police Commissioner and Former NYC Fire Commissioner
• Assistant Director of the DEA
• Chief of the Witness Security Division, U.S. Marshals Service
Robert Liscouski (Board Member)
• First Assistant Secretary for Infrastructure Protection at DHS
• 11 years with the Diplomatic Security Service at the State Department
• Director of Information Assurance for The Coca-Cola Company
Dr. Bill McGann (COO, Board Member)
• Original developer of ETD technology at Ion Track, successfully sold to GE
• Chief Technology Officer at GE Homeland Security
• Strong TSA/TSL relationships
Mo McGowan (Advisor)
• One of the founders of the Transportation Security Administration
• Assistant Administrator for Security Operations
• General Manager for Cargo and Supply Chain Security

16. Made in USA
Implant Sciences currently
employs 75 direct employees and
an additional 10-20 through
contract manufacturers
We source 95% of our inputs
locally, affecting an additional 50-
75 jobs
For every 45 incremental
units, we can create another U.S.
job
Company Confidential 16

17. Thank You
We welcome your questions
and comments
Company Confidential 17
COSD1402